252 related articles for article (PubMed ID: 27321761)
21. Clostridium perfringens epsilon prototoxin mutant rpETX
Du J; Wang T; Xu L; Wang C; Liu Y; Pan C; Chen X; Zhu Z; Luo Y; Yin C
Vaccine; 2023 Jul; 41(32):4762-4770. PubMed ID: 37357076
[TBL] [Abstract][Full Text] [Related]
22. New Mutants of Epsilon Toxin from
Dorca-Arévalo J; Gómez de Aranda I; Blasi J
Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448898
[TBL] [Abstract][Full Text] [Related]
23. Clostridium perfringens Epsilon Toxin Mutant I51C as a Recombinant Vaccine Candidate Against Enterotoxemia.
Nakhaipour E; Kariminik A; Alimolaei M; Bafti MS
Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345990
[TBL] [Abstract][Full Text] [Related]
24. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides.
Minami J; Katayama S; Matsushita O; Matsushita C; Okabe A
Microbiol Immunol; 1997; 41(7):527-35. PubMed ID: 9272698
[TBL] [Abstract][Full Text] [Related]
25. Lung endothelial cells are sensitive to epsilon toxin from Clostridium perfringens.
Dorca-Arévalo J; Dorca E; Torrejón-Escribano B; Blanch M; Martín-Satué M; Blasi J
Vet Res; 2020 Feb; 51(1):27. PubMed ID: 32093740
[TBL] [Abstract][Full Text] [Related]
26. Native or Proteolytically Activated NanI Sialidase Enhances the Binding and Cytotoxic Activity of Clostridium perfringens Enterotoxin and Beta Toxin.
Theoret JR; Li J; Navarro MA; Garcia JP; Uzal FA; McClane BA
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29038129
[TBL] [Abstract][Full Text] [Related]
27. Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia.
Bokori-Brown M; Hall CA; Vance C; Fernandes da Costa SP; Savva CG; Naylor CE; Cole AR; Basak AK; Moss DS; Titball RW
Vaccine; 2014 May; 32(23):2682-7. PubMed ID: 24709588
[TBL] [Abstract][Full Text] [Related]
28.
Mander KA; Uzal FA; Williams R; Finnie JW
J Vet Diagn Invest; 2020 Mar; 32(2):277-281. PubMed ID: 31608815
[No Abstract] [Full Text] [Related]
29. Identification of a lambda toxin-negative Clostridium perfringens strain that processes and activates epsilon prototoxin intracellularly.
Harkness JM; Li J; McClane BA
Anaerobe; 2012 Oct; 18(5):546-52. PubMed ID: 22982043
[TBL] [Abstract][Full Text] [Related]
30. The pore structure of Clostridium perfringens epsilon toxin.
Savva CG; Clark AR; Naylor CE; Popoff MR; Moss DS; Basak AK; Titball RW; Bokori-Brown M
Nat Commun; 2019 Jun; 10(1):2641. PubMed ID: 31201325
[TBL] [Abstract][Full Text] [Related]
31. Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants.
Lobato FC; Lima CG; Assis RA; Pires PS; Silva RO; Salvarani FM; Carmo AO; Contigli C; Kalapothakis E
Vaccine; 2010 Aug; 28(38):6125-7. PubMed ID: 20670910
[TBL] [Abstract][Full Text] [Related]
32. Intramural Vascular Edema in the Brain of Goats With Clostridium perfringens Type D Enterotoxemia.
Ortega J; Verdes JM; Morrell EL; Finnie JW; Manavis J; Uzal FA
Vet Pathol; 2019 May; 56(3):452-459. PubMed ID: 30663524
[TBL] [Abstract][Full Text] [Related]
33. Identification of the channel-forming domain of Clostridium perfringens Epsilon-toxin (ETX).
Knapp O; Maier E; Benz R; Geny B; Popoff MR
Biochim Biophys Acta; 2009 Dec; 1788(12):2584-93. PubMed ID: 19835840
[TBL] [Abstract][Full Text] [Related]
34. Amino acid residue Y196E substitution and C-terminal peptide synergistically alleviate the toxicity of Clostridium perfringens epsilon toxin.
Yao W; Kang L; Gao S; Zhuang X; Zhang T; Yang H; Ji B; Xin W; Wang J
Toxicon; 2015 Jun; 100():46-52. PubMed ID: 25912943
[TBL] [Abstract][Full Text] [Related]
35. Naturally acquired antibodies against Clostridium perfringens epsilon toxin in goats.
Veschi JL; Bruzzone OA; Losada-Eaton DM; Dutra IS; Fernandez-Miyakawa ME
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):198-202. PubMed ID: 18538416
[TBL] [Abstract][Full Text] [Related]
36. Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheep, goats, and mice.
Garcia JP; Adams V; Beingesser J; Hughes ML; Poon R; Lyras D; Hill A; McClane BA; Rood JI; Uzal FA
Infect Immun; 2013 Jul; 81(7):2405-14. PubMed ID: 23630957
[TBL] [Abstract][Full Text] [Related]
37. The Myelin and Lymphocyte Protein MAL Is Required for Binding and Activity of Clostridium perfringens ε-Toxin.
Rumah KR; Ma Y; Linden JR; Oo ML; Anrather J; Schaeren-Wiemers N; Alonso MA; Fischetti VA; McClain MS; Vartanian T
PLoS Pathog; 2015 May; 11(5):e1004896. PubMed ID: 25993478
[TBL] [Abstract][Full Text] [Related]
38. The early effects of Clostridium perfringens type D epsilon toxin in ligated intestinal loops of goats and sheep.
Fernandez Miyakawa ME; Uzal FA
Vet Res Commun; 2003 Apr; 27(3):231-41. PubMed ID: 12777097
[TBL] [Abstract][Full Text] [Related]
39. Calcium enhances binding of Clostridium perfringens epsilon toxin to sulfatide.
Gil C; Dorca-Arévalo J; Blasi J
Biochim Biophys Acta Biomembr; 2019 Jan; 1861(1):161-169. PubMed ID: 30463699
[TBL] [Abstract][Full Text] [Related]
40. Systematic evaluation of membrane-camouflaged nanoparticles in neutralizing Clostridium perfringens ε-toxin.
Xu J; Li D; Kang L; Liu T; Huang J; Li J; Lv J; Wang J; Gao S; Li Y; Yuan B; Zhao B; Wang J; Xin W
J Nanobiotechnology; 2023 Mar; 21(1):95. PubMed ID: 36932366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
